Company Filing History:
1 out of 319 
1 out of 357 
1 out of 378 
Years Active: 2019-2021
Title: Jan Stampfuss: A Trailblazer in Innovation
Introduction: Jan Stampfuss, a renowned inventor based in Duesseldorf, DE, has made significant contributions to the world of inventions with his groundbreaking work that continues to inspire future generations of inventors and innovators.
Latest Patents:
1. Substituted oxopyridine derivatives: Jan Stampfuss's invention of substituted oxopyridine derivatives has paved the way for the development of medicaments for treating cardiovascular disorders, particularly thrombotic or thromboembolic disorders, oedemas, and ophthalmic disorders.
2. Transdermal administration of memantine: His innovation in transdermal therapeutic systems (TTS) incorporating memantine as an active ingredient has opened new possibilities for treating diseases of the central nervous system.
Career Highlights: Jan Stampfuss has two patents to his name, showcasing his expertise and dedication to advancing healthcare through innovative solutions. His work at Bayer Pharma Aktiengesellschaft and Lts Lohmann Therapie-Systeme AG has been instrumental in shaping the field of pharmaceuticals.
Collaborations: Throughout his career, Jan Stampfuss has collaborated with talented individuals such as Eloisa Jimenez Nunez and Jens Ackerstaff, pooling their collective knowledge and skills to drive forward pioneering projects in the pharmaceutical industry.
Conclusion: Jan Stampfuss stands as a beacon of innovation and creativity, leaving a lasting impact on the world of inventions. His dedication to pushing boundaries and his collaborative spirit continue to inspire and shape the future of inventors and innovators worldwide.